ย
Today we are watching…
1.ย Wendy’s (#wen)
ย Wendyโs, the restaurant chain, wants to take something new, to somewhere new! By raising investorsโ expectations about a breakfast menu in Europe, the company has raised its stock price. Soon, the company will have meat alternatives on offer, diners popping up in the post-Brexit UK, and even a โblack burger.โ The less said about that, the better! A PowerPoint prezy to shareholders on Friday was mainly directed at skeptical investors. Wendyโs has tried to introduce breakfast three times before without success, so it needs to score a big W to fend off a reputation for let downs on Wall Street. Wendyโs investors are playing a game of high risk and high reward!
2. Eli Lilly (#lilly)
ย This biotech behemoth has gone through a Federal Drugs Authority (FDA) headache, all so that we can be free of them forever. After an ungodly amount of paperwork was filed to the government, Reyvow, a migraine relief antidote, was cleared for commercial use on Friday. Hurray! Its price is still up in the air, but getting past the be-all and end-all, dream-defining FDA judgment is a massive win for Eli Lilly. It claims the bragging rights over Novartis, which has a migraine drug in lieu, and will now get a head start on marketing Reyvow! Will Lilly make it count?